Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The company says the results were strong enough to launch an extensive Phase 3 development program that will include obesity, type 2 diabetes, cardiovascular outcomes, and kidney disease studies
Consult a physician if pregnant or nursing, taking medication, or if you have a medical condition
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and liraglutide, are increasingly prescribed in the UK for type 2 diabetes and weight management
The critical difference is how many receptors each drug activates
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kober LV, Lawson FC, Ping L, Wei X, Lewis EF, et al
US$ 26.47
US$ 23.30
US$ 20.53
US$ 28.40
US$ 28.17
US$ 28.39
